The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Open accessAbstract
Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Several conditions, such as primary sclerosing cholangitis (PSC), are risk factors. Noninvasive differential diagnosis between intrahepatic CCA and hepatocellular carcinoma (HCC) is sometimes difficult. Accurate noninvasive biomarkers for PSC, CCA, and HCC are not available. In the search for novel biomarkers, serum extracellular vesicles (EV) were isolated from CCA (n = 43), PSC (n = 30), or HCC (n = 29) patients and healthy individuals (control, n = 32); and their protein content was characterized. By using nanoparticle tracking analysis, serum EV concentration was found to be higher in HCC than in all the other groups. Round morphology (by transmission electron microscopy), size (∼180 nm diameter by nanoparticle tracking analysis), and markers (clusters of differentiation 9, 63, and 81 by immunoblot) indicated that most serum EV were exosomes. Proteome profiles (by mass spectrometry) revealed multiple differentially expressed proteins among groups. Several of these proteins showed high diagnostic values with maximum area under the receiver operating characteristic curve of 0.878 for CCA versus control, 0.905 for CCA stage I‐II versus control, 0.789 for PSC versus control, 0.806 for noncirhottic PSC versus control, 0.796 for CCA versus PSC, 0.956 for CCA stage I‐II versus PSC, 0.904 for HCC versus control, and 0.894 for intrahepatic CCA versus HCC. Proteomic analysis of EV derived from CCA human cells in vitro revealed higher abundance of oncogenic proteins compared to EV released by normal human cholangiocytes. Orthotopic implant of CCA human cells in the liver of immunodeficient mice resulted in the release to serum of EV containing some similar human oncogenic proteins. Conclusion: Proteomic signatures found in serum EV of CCA, PSC, and HCC patients show potential usefulness as diagnostic tools. (H epatology 2017;66:1125‐1143).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Self-citationTumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Mass Spectrometry and Protein Analysis
Domon, B., & Aebersold, R. (2006) · Science · doi:10.1126/science.1124619 · Cited by 2,181
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Razumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Self-citationBanales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Self-citationExosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Azmi, A. S., Bao, B., & Sarkar, F. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9441-9 · Cited by 1,167
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
Primary Sclerosing Cholangitis
Lazaridis, K. N., & LaRusso, N. F. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1506330 · Cited by 505
Primary Sclerosing Cholangitis
(2007) · Gastroenterology Nursing · doi:10.1097/01.sga.0000267930.44372.16 · Cited by 382
Microparticles: biomarkers and beyond
Burger, D., Schock, S., Thompson, C. S., Montezano, A. C., Hakim, A. M., & Touyz, R. M. (2013) · Clinical Science · doi:10.1042/cs20120309 · Cited by 362
Levy, C., Lymp, J., Angulo, P., Gores, G. J., Larusso, N., & Lindor, K. D. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2927-8 · Cited by 339
Self-citationMasyuk, A. I., Huang, B. Q., Ward, C. J., Gradilone, S. A., Banales, J. M., Masyuk, T. V., Radtke, B., Splinter, P. L., & LaRusso, N. F. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00093.2010 · Cited by 285
Self-citationAn, T., Qin, S., Xu, Y., Tang, Y., Huang, Y., Situ, B., Inal, J. M., & Zheng, L. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27522 · Cited by 282
Banales, J. M., Sáez, E., Úriz, M., Sarvide, S., Urribarri, A. D., Splinter, P., Tietz Bogert, P. S., Bujanda, L., Prieto, J., Medina, J. F., et al. (2012) · Hepatology · doi:10.1002/hep.25691 · Cited by 250
Self-citationExtracellular Vesicles in Liver Pathobiology: Small Particles With Big Impact
Hirsova, P., Ibrahim, S. H., Verma, V. K., Morton, L. A., Shah, V. H., LaRusso, N. F., Gores, G. J., & Malhi, H. (2016) · Hepatology · doi:10.1002/hep.28814 · Cited by 229
Self-citationLi, L., Masica, D., Ishida, M., Tomuleasa, C., Umegaki, S., Kalloo, A. N., Georgiades, C., Singh, V. K., Khashab, M., Amateau, S., et al. (2014) · Hepatology · doi:10.1002/hep.27050 · Cited by 223
Lankisch, T. O., Metzger, J., Negm, A. A., Voβkuhl, K., Schiffer, E., Siwy, J., Weismüller, T. J., Schneider, A. S., Thedieck, K., Baumeister, R., et al. (2011) · Hepatology · doi:10.1002/hep.24103 · Cited by 162
Haga, H., Yan, I. K., Takahashi, K., Wood, J., Zubair, A., & Patel, T. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.24900 · Cited by 159
Self-citationLiang, B., Zhong, L., He, Q., Wang, S.-C., Pan, Z., Wang, T., & Zhao, Y. (2015) · Medical Science Monitor · doi:10.12659/msm.895040 · Cited by 154
Li, L., Piontek, K., Ishida, M., Fausther, M., Dranoff, J. A., Fu, R., Mezey, E., Gould, S. J., Fordjour, F. K., Meltzer, S. J., et al. (2016) · Hepatology · doi:10.1002/hep.28735 · Cited by 142
Metzger, J., Negm, A. A., Plentz, R. R., Weismüller, T. J., Wedemeyer, J., Karlsen, T. H., Dakna, M., Mullen, W., Mischak, H., Manns, M. P., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302047 · Cited by 140
Clapéron, A., Mergey, M., Ho-Bouldoires, T. H. N., Vignjevic, D. M., Wendum, D., Chrétien, Y., Merabtene, F., Frazao, A., Paradis, V., Housset, C., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.033 · Cited by 132
Update on primary sclerosing cholangitis
Karlsen, T. H., & Boberg, K. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.015 · Cited by 123
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
Jiang, S.-S., Weng, D., Wang, Q.-J., Pan, K., Zhang, Y., Li, Y.-Q., Li, X. H., Zhao, J.-J., He, J., Lv, L., et al. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0273-3 · Cited by 72
Urribarri, A. D., Muñoz-Garrido, P., Perugorria, M. J., Erice, O., Merino-Azpitarte, M., Arbelaiz, A., Lozano, E., Hijona, E., Jiménez-Agüero, R., Fernández‐Barrena, M. G., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305281 · Cited by 64
Self-citationMuñoz-Garrido, P., Marı́n, J. J. G., Perugorria, M. J., Urribarri, A. D., Erice, O., Sáez, E., Úriz, M., Sarvide, S., Portu, A., Concepcion, A. R., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.023 · Cited by 64
Self-citationPolymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma
Yue, X., Ai, J., Xu, Y., Chen, Y., Huang, M., Yang, X., Hu, B., Zhang, H., He, C.-X., Yang, X., et al. (2017) · Hepatology · doi:10.1002/hep.29036 · Cited by 60
Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers
González, E., & Falcón‐Pérez, J. M. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1043272 · Cited by 58
Differential Membrane Proteomics Using 18O-Labeling To Identify Biomarkers for Cholangiocarcinoma
Kristiansen, T. Z., Gowda, H., Grønborg, M., Maitra, A., & Pandey, A. (2008) · Journal of Proteome Research · doi:10.1021/pr800215n · Cited by 46
TROP2 Correlates with Microvessel Density and Poor Prognosis in Hilar Cholangiocarcinoma
Ning, S., Guo, S., Xie, J., Xu, Y., Lü, X., & Chen, Y. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2105-1 · Cited by 41
Lin, Z.-Y., Liang, Z.-X., Zhuang, P.-L., Chen, J.-W., Cao, Y., Yan, L., Yun, J., Xie, D., & Cai, M.-Y. (2016) · BMC Cancer · doi:10.1186/s12885-016-2827-7 · Cited by 38
Sasaki, M., Matsubara, T., Yoneda, N., Nomoto, K., Tsuneyama, K., Sato, Y., & Nakanuma, Y. (2012) · Histopathology · doi:10.1111/his.12016 · Cited by 36
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Saisho, T., Okusaka, T., Ueno, H., Morizane, C., & Okada, S. (2005) · PubMed · Cited by 26
Razumilava, N., & Gores, G. J. (2016) · Clinical Liver Disease · doi:10.1002/cld.567 · Cited by 25
Self-citationGetting to the heart of the matter in cancer: Novel approaches to targeting cancer stem cells
Colvin, H., & Mori, M. (2017) · Proceedings of the Japan Academy. Series B, Physical and biological sciences · doi:10.2183/pjab.93.009 · Cited by 13
The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer Surveillance
Kelly, S. L., & Bird, T. G. (2016) · Journal of Immunobiology · doi:10.4172/2476-1966.1000116 · Cited by 10
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationCholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Self-citationFrom NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Circulating Extracellular Vesicles in Human Disease
Shah, R., Patel, T., & Freedman, J. E. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1704286 · Cited by 749
Self-citationLiquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 712
Metadata
- Authors
- Arbelaiz, A., Azkargorta, M., Krawczyk, M., Santos‐Laso, A., Lapitz, A., Perugorria, M. J., Erice, O., Gonzalez, E., Jimenez‐Agüero, R., Lacasta, A., Ibarra, C., Sanchez‐Campos, A., Jimeno, J. P., Lammert, F., Milkiewicz, P., Marzioni, M., Macias, R. I. R., Marin, J. J. G., Patel, T., Gores, G. J., Martinez, I., Elortza, F., Falcon‐Perez, J. M., Bujanda, L., & Banales, J. M.
- Venue
- Hepatology
- Published
- 2017-08-26
- Volume
- 66
- Issue
- 4
- Pages
- 1125-1143
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2619076775
- Cited by
- 289
- References
- 40
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.